Giving Patients with Erectile Dysfunction the Opportunity to Try All Three Available Phosphodiesterase Type 5 Inhibitors Contributes to Better Long-Term Treatment Compliance

There are three phosphodiesterase type 5 (PDE5) inhibitors marketed, sildenafil, Vardenafil, and tadalafil for oral treatment of erectile dysfunction (ED). Although the treatment is simple and mostly effective, around 50% has ceased to use the medication within 2 years. One recently described way to...

Ausführliche Beschreibung